Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2005
12/29/2005US20050288262 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression
12/29/2005US20050288254 Treating sepsis or septic shock by administering 1-stearoyl, 1-palmitoyl-, 1-myristoyl- lysophosphatidylcholine, or 1-oleoyllysophosphatidylcholine or sphingosylphosphorylcholine.
12/29/2005US20050288219 Osteoprotegerin in milk
12/29/2005US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/29/2005US20050287546 Novel proteases
12/29/2005US20050287168 Recombinant spores
12/29/2005US20050287162 Recombinant fowlpox virus
12/29/2005US20050287144 For the modulation of signal activities controlled by NF-kappa B-inducing kinase (NIK); cancer , rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, asthma, cardiac infarct, Alzheimer's disease, or atherosclerosis
12/29/2005US20050287142 Remedies or preventives for rheumatoid arthritis
12/29/2005US20050287079 Combinations of formoterol and fluticasone propionate for asthma
12/29/2005DE19748040B4 Carbonsäurederivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, die diese Verbindungen enthalten Carboxylic acid derivatives, processes for their preparation and pharmaceutical preparations containing these compounds
12/29/2005DE102005026380A1 Mittel zur Unterdrückung von Entzündungen, umfassend Zinkpyrrolidoncarboxylat Means for suppressing inflammation, comprising zinc pyrrolidonecarboxylate
12/29/2005CA2570709A1 Solid orally ingestible formulations of tetrodotoxin
12/29/2005CA2570531A1 Indoles useful in the treatment of inflammation
12/29/2005CA2570503A1 A method of improving the medical treatment of pain
12/29/2005CA2570389A1 Treatments comprising strontium for rheumatic and arthritic diseases and pain
12/29/2005CA2570365A1 Indoles useful in the treatment of inflammation
12/29/2005CA2570363A1 Indoles useful in the treatment of inflammation
12/29/2005CA2569697A1 A pharmaceutical composition and its use
12/29/2005CA2569687A1 Methods of modulating cellular activity involving sphingosine kinase and agents for same, and sphingosine kinase variants
12/29/2005CA2568601A1 Peptide-based compounds
12/29/2005CA2568570A1 Method of treating granuloma annulare or sarcoid
12/28/2005EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/28/2005EP1609803A1 Modified antibody against cd22 and utilization thereof
12/28/2005EP1609797A1 Compound having affinity with calcified tissue
12/28/2005EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine
12/28/2005EP1609477A1 Irrigation solution and use thereof for the perioperative inhibition of pain/inflammation and/or spasm at a vascular structure
12/28/2005EP1609472A1 Therapeutic agent for hemorrhoidal disease
12/28/2005EP1609468A2 A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis
12/28/2005EP1608651A1 Protein kinase inhibitors
12/28/2005EP1608623A1 Metal ion chelators and therapeutic use thereof
12/28/2005EP1608616A1 Biphenyl carboxylic amide p38 kinase inhibitors
12/28/2005EP1608405A2 Nitric oxide in treatment of inflammation
12/28/2005EP1608400A1 Elevation of adenosine level by cytokine-induced expression of cd73
12/28/2005EP1608396A2 Use of soluble cd14 for treatment of diseases
12/28/2005EP1608383A1 A formulation comprising a bacterial strain
12/28/2005EP1608363A1 Methods for treating inflammatory conditions or inhibiting jnk
12/28/2005EP1608351A2 Compositions containing superoxide dismutase and a selected et 5-lipoxygenase inhibitor and uses thereof
12/28/2005EP1608349A1 Oral delivery system comprising an antibacterial and an anti-inflammatory agent
12/28/2005EP1470124B1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES
12/28/2005EP1435983B1 Concentrate comprising green tea, grape skin extract and grape seed extract, the production thereof and the use of the same
12/28/2005EP1382604B1 Quinoline derivative having azolyl group and quinazoline derivative
12/28/2005EP1377593B1 2-amino-propanol derivatives
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1123114B1 Virus-like particles for the induction of autoantibodies
12/28/2005EP1024802B1 Cannabinol-11-oic acid derivatives useful as antiinflammatory agents and analgesics
12/28/2005CN1714096A Mmp inhibitors
12/28/2005CN1714093A Diazinopyrimidines
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1713926A Peritoneal dialysis method
12/28/2005CN1713899A Transdermal therapeutic system with fentanyl or related substances
12/28/2005CN1713894A Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid
12/28/2005CN1233645C Novel oripavine derivative and its medical use
12/28/2005CN1233415C CD26/DPP IV application in preparation of medicine for treating and/or diagnosing disease
12/28/2005CN1233400C Fever bringing down formulation for preventing virus and its prepn. method
12/28/2005CN1233399C Effervescence tablet of radix isatidis and its preparation
12/28/2005CN1233394C Rheumatic arthritis treating medicine
12/28/2005CN1233381C Bone fracture analgesic ointment
12/28/2005CN1233380C Special effect medicine for pyretolysis
12/28/2005CN1233371C Quick effect toothache plaster
12/28/2005CN1233365C External-use medicine for treating rheumatoid arthritis and its preparing method
12/28/2005CN1233349C Heat-clearing, toxin-expelling, swell-subsiding Chinese medicinal composition and its use
12/28/2005CN1233336C Chinese medicine for treating rheumatic arthritis
12/28/2005CN1233334C Oral liquid for detoxicating and dispelling wind
12/28/2005CN1233333C Process for preparing Tibetan medicines
12/28/2005CN1233326C Use of glede tea alcohol extract in preparation of antiphlogistic immune pharmaceutical
12/28/2005CN1233325C Drug for treatment of osteonecrosis and for management of patients at risk of steonecrosis
12/28/2005CN1233323C Orally disintegrating tablet of meloxicam and its preparation
12/28/2005CN1233310C Preparing process for rheumatic plaster
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979683 Polymerase enzyme inhibitors
12/27/2005US6979554 polypeptide has an affinity for a phospholipid selected from a phosphatidylserine, a phosphatidylethanolamine, a phosphatidylinositol, a phosphatidic acid, and a cardiolipin
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005CA2428271C Cyanopyrrolidine derivatives as inhibitors of dpp-iv
12/22/2005WO2005121340A1 Novel galectin 8 modification protein and use thereof
12/22/2005WO2005121135A1 Vla-4 inhibitor
12/22/2005WO2005121129A1 Novel propenone derivatives containing aromatic rings, a maufacturing process thereof and a composition containing the same using as an antiinflammatory agent
12/22/2005WO2005121076A1 (diaryl-methyl)-malononitriles and their use as estrogen receptor ligands
12/22/2005WO2005120522A1 Rheumatism preventive or therapeutic agent and beverage each comprising reduced-deuterium water
12/22/2005WO2005120491A1 Remedy or preventive for inflammatory bowel disease
12/22/2005WO2005120485A1 Regulator of physiological function of ghrelin and use thereof
12/22/2005WO2005120484A1 Regulator for physiological functions of ghrelin
12/22/2005WO2005097814A3 Composition and method for inhibiting platelet aggregation
12/22/2005WO2005046569A3 Pharmaceutical compositions for the treatment of sars
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005WO2002083874A3 Endothelial cell expression patterns
12/22/2005US20050283019 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease
12/22/2005US20050282905 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
12/22/2005US20050282900 Inhibitors of alpha4 mediated cell adhesion
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282880 Novel 1H-indazole compounds
12/22/2005US20050282876 Inhibitors of IMPDH enzyme
12/22/2005US20050282871 3-(3,5-Disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282845 Substituted pyrimidines as selective cyclooxygenase-2 inhibitors
12/22/2005US20050282844 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
1 ... 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 ... 1272